Arterial pulmonary hypertension in noncardiac intensive care unit
- PMID: 19183752
- PMCID: PMC2605326
- DOI: 10.2147/vhrm.s3998
Arterial pulmonary hypertension in noncardiac intensive care unit
Abstract
Pulmonary artery pressure elevation complicates the course of many complex disorders treated in a noncardiac intensive care unit. Acute pulmonary hypertension, however, remains underdiagnosed and its treatment frequently begins only after serious complications have developed. Significant pathophysiologic differences between acute and chronic pulmonary hypertension make current classification and treatment recommendations for chronic pulmonary hypertension barely applicable to acute pulmonary hypertension. In order to clarify the terminology of acute pulmonary hypertension and distinguish it from chronic pulmonary hypertension, we provide a classification of acute pulmonary hypertension according to underlying pathophysiologic mechanisms, clinical features, natural history, and response to treatment. Based on available data, therapy of acute arterial pulmonary hypertension should generally be aimed at acutely relieving right ventricular (RV) pressure overload and preventing RV dysfunction. Cases of severe acute pulmonary hypertension complicated by RV failure and systemic arterial hypotension are real clinical challenges requiring tight hemodynamic monitoring and aggressive treatment including combinations of pulmonary vasodilators, inotropic agents and systemic arterial vasoconstrictors. The choice of vasopressor and inotropes in patients with acute pulmonary hypertension should take into consideration their effects on vascular resistance and cardiac output when used alone or in combinations with other agents, and must be individualized based on patient response.
Keywords: acute cor pulmonale; acute pulmonary hypertension; cor pulmonale; pulmonary hypertension; right heart failure.
Figures

Similar articles
-
[Experts consensus on the management of the right heart function in critically ill patients].Zhonghua Nei Ke Za Zhi. 2017 Dec 1;56(12):962-973. doi: 10.3760/cma.j.issn.0578-1426.2017.12.017. Zhonghua Nei Ke Za Zhi. 2017. PMID: 29202543 Chinese.
-
The management of acute pulmonary arterial hypertension.Cardiovasc Ther. 2011 Jun;29(3):153-75. doi: 10.1111/j.1755-5922.2009.00095.x. Epub 2010 Jun 18. Cardiovasc Ther. 2011. PMID: 20560976 Review.
-
Pulmonary hypertension in the intensive care unit. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.Heart. 2016 May;102 Suppl 2:ii57-66. doi: 10.1136/heartjnl-2015-307774. Heart. 2016. PMID: 27053699
-
The prevalence and course of pulmonary hypertension and right ventricular dysfunction in patients undergoing orthotopic heart transplantation.Transplant Proc. 2013;45(10):3538-41. doi: 10.1016/j.transproceed.2013.08.103. Transplant Proc. 2013. PMID: 24314953
-
Pathophysiology of severe pulmonary hypertension in the critically ill patient.Minerva Anestesiol. 2004 Apr;70(4):233-7. Minerva Anestesiol. 2004. PMID: 15173702 Review.
Cited by
-
Demographics and Risk Factors of Pediatric Pulmonary Hypertension Readmissions.Cureus. 2021 Oct 23;13(10):e18994. doi: 10.7759/cureus.18994. eCollection 2021 Oct. Cureus. 2021. PMID: 34853737 Free PMC article.
-
Pulmonary Hypertension an Independent Risk Factor for Death in Intensive Care Unit: Correlation of Hemodynamic Factors with Mortality.Clin Med Insights Circ Respir Pulm Med. 2015 Jun 23;9:27-33. doi: 10.4137/CCRPM.S22199. eCollection 2015. Clin Med Insights Circ Respir Pulm Med. 2015. PMID: 26124692 Free PMC article.
-
Dynamic changes of pulmonary arterial pressure in perinatal neonates with pulmonary and extrapulmonary acute lung injury/respiratory distress syndrome.Medicine (Baltimore). 2019 Mar;98(11):e14830. doi: 10.1097/MD.0000000000014830. Medicine (Baltimore). 2019. PMID: 30882668 Free PMC article.
-
Peptide-coated liposomal fasudil enhances site specific vasodilation in pulmonary arterial hypertension.Mol Pharm. 2014 Dec 1;11(12):4374-84. doi: 10.1021/mp500456k. Epub 2014 Nov 4. Mol Pharm. 2014. PMID: 25333706 Free PMC article.
-
Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumonia.Nitric Oxide. 2021 Nov 1;116:7-13. doi: 10.1016/j.niox.2021.08.003. Epub 2021 Aug 13. Nitric Oxide. 2021. PMID: 34400339 Free PMC article.
References
-
- Adrie C, Holzmann A, Hirani WM, et al. Effects of intravenous Zaprinast and inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of acute respiratory distress syndrome. Anesthesiology. 2000;93:422–30. - PubMed
-
- Albertini M, Ciminaghi B, Mazzola S, et al. Improvement of respiratory function by bosentan during endotoxic shock in the pig. Prostaglandins Leukot Essent Fatty Acids. 2001;65:103–8. - PubMed
-
- Arafa OE, Geiran OR, Andersen K, et al. Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg. 2000;70:1587–93. - PubMed
-
- Atz AM, Wessel DL. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology. 1999;91:307–10. - PubMed
-
- Aubert S, Leprince P, Bonnet N, et al. Limited mechanical circulatory support following orthotopic heart transplantation. Interact Cardiovasc Thorac Surg. 2006;5:88–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical